Reason for MICU transfer: Hypotension   Major Surgical or Invasive Procedure: Central Line placement and removal   History of Present Illness: Ms. [**Known lastname 57655**] is a 63F with a history of melanoma originally diagnosed [**2098**] who is admitted for cycle 1 week 2 of HD IL-2 therapy.
She was initially treated with 32 weeks of interferon but course was terminated due to peripheral neuropathy.
She underwent hip stabilization surgery on [**2105-1-7**] and biopsy confirmed melanoma.
Re-staging was pertinent for stable liver/lung lesions and normal LDH so high-dose IL-2 therapy was recommended.
She underwent a first treatment cycle [**Date range (1) 69193**], which was complicated by pulmonary edema (two doses held) and toxic encephalopathy (two doses held; mental status improved to baseline).
She is recovered well from week 1o f theraoy and is here to begin week of HD Il-2 on cycle 1.  Review of systems: (+) Per HPI (-) Denies fever, chills, night sweats, recent weight loss or gain.
Denies chest pain, chest pressure, palpitations, or weakness.
Past Medical History: Past Medical History: - Melanoma - Hypertension - Hypercholesterolemia - Depression - Hypothyroidism - S/p hip stabilization [**2105-1-7**] - S/p TAH with BSO for fibroids   Social History: Lives alone in [**State 1727**].
Skin: Diffuse, confluent, maculopapular, erythematous, blanching rash over face, torso, extremities associated with dry/flaking skin.
Pertinent Results: [**2105-3-5**] 04:00AM BLOOD Glucose-114* UreaN-42* Creat-3.0*# Na-130* K-5.1 Cl-102 HCO3-19* AnGap-14 [**2105-3-8**] 04:00AM BLOOD Glucose-83 UreaN-58* Creat-2.5* Na-129* K-4.5 Cl-99 HCO3-22 AnGap-13 [**2105-3-4**] 04:00AM BLOOD Glucose-116* UreaN-33* Creat-1.8*# Na-133 K-5.4* Cl-104 HCO3-19* AnGap-15 [**2105-3-3**] 04:11AM BLOOD Na-136 K-3.4 Cl-106 HCO3-21* AnGap-12  Brief Hospital Course: Ms. [**Known lastname 57655**] was admitted to [**Hospital1 18**] for Cycle 1, week 2 of HD IL-2 therapy for metastatic melanoma.
Her dosing schedule was changed to [**Hospital1 **] dosing on day 2 given the previous week's neurotoxicity and other side effects.
She was also placed on telemetry given myocarditis observed during the previous week.
She underwent CVL placement and with confirmation, she began treatment on [**2105-3-2**].
Her IV fluid was maintained at 50 ml/hr given pulmonary edema seen on week 1 however increased back to 75 ml/hr with hyperkalemia and acute renal failure.
Her course was complicated hypotension hypovolemic shock requiring further elevation of the pressor support and ultimately being transferred to ICU for further support on day +5.
She had acute renal failure with peak Cr of 3.0, her urine out put, daily labs were closely monitored and had continuous IVF for support.
Medications on Admission: Medications at home: Pharmacy is [**Last Name (un) 9997**] in [**Location (un) **] [**State 1727**].
- Acetaminophen 325-650 mg q.i.d.
- Sarna lotion topically q.i.d.
- Cephalexin 500 mg b.i.d.
- Diphenhydramine 25-50 mg q.i.d.
- Lomotil 1-2 tablets b.i.d.
- Cymbalta 60 mg p.o.
- Lasix 20 mg p.o.
- Levothyroxine 125 mcg p.o.
- Lorazepam 0.5-1 mg t.i.d.
- Oxycodone 5-10 mg q.4 h. p.r.n.
- Prochlorperazine 10 mg q.i.d.
- Zantac 150 mg p.o.
- Eucerin cream topically.
- BP meds at home (patient does not know names/doses; likely lisinopril-HCTZ 20-25 mg PO daily and metoprolol succinate 25 mg PO QHS per OMR records; will attempt to confirm with pharmacy)  Discharge Medications: 1. diphenhydramine HCl 25 mg Capsule Sig: [**12-15**] Capsules PO Q6H (every 6 hours) as needed for pruritis.
Disp:*1 bottle* Refills:*0* 3. cephalexin 500 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) for 5 days.
Disp:*10 Capsule(s)* Refills:*0* 4. furosemide 20 mg Tablet Sig: One (1) Tablet PO once a day for 5 days: please take until pre treatment weight is acheived.
Disp:*5 Tablet(s)* Refills:*0* 5. gabapentin 100 mg Capsule Sig: [**12-16**] Capsules PO TID (3 times a day) as needed for itching.
